Moderate Dietary Supplementation with Omega-3 Fatty Acids Does Not Impact Plasma Von Willebrand Factor Profile in Mildly Hypertensive Subjects

Figure 1

Measurement of the incorporation of long chain polyunsaturated fatty acids (LC PUFA) into erythrocyte membrane phospholipids at baseline and after 12 weeks of treatment with 2.52 g/day n-3 PUFAs. Parameters measured were the omega-3 index (a), the percent arachidonic acid (b), and the n-6 to n-3 PUFA ratio (c) (one-way ANOVA, ^*: ; ^**: ). Data are expressed as mean ± SEM. W12, Week 12; HT, hypertensive; NT, normotensive; n-3, omega-3 LC PUFA.

(a)

(b)

(c)